Display Options:
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Depressive Disorder, Major; Fibromyalgia; Hemangioma, Cavernous, Central Nervous System; Kidney Diseases; Memory Disorders; Orthostatic Intolerance; Pulmonary Disease, Chronic Obstructive; Alcohol Drinking; Anemia, Sickle Cell; Asthma; Breast Neoplasms; Burns; Carcinoma, Hepatocellular; Carcinoma, Renal Cell; Cocaine-Related Disorders; Diabetes Mellitus, Type 1; Dystocia; Hemangiosarcoma; Hypertension; Hypotension; Hypotension, Orthostatic; Low Back Pain; Lymphedema; Macular Degeneration; Marfan Syndrome; Melanoma; Migraine with Aura; Migraine without Aura; Multiple Myeloma; Pain; Pancreatic Neoplasms; Panic Disorder; Papilloma; Retinopathy of Prematurity; Shoulder Pain; Sleep Apnea, Obstructive; Stomach Neoplasms; Stress Disorders, Traumatic, Acute; Stroke; Substance-Related Disorders; Syncope; Wounds and Injuries; Anxiety; Ascites; Brain Injuries; Colorectal Neoplasms; Death, Sudden, Cardiac; Esophageal and Gastric Varices; Headache; Hemangioma; Hypertension, Portal; Liver Cirrhosis; Migraine Disorders; Myocardial Infarction; Myocardial Ischemia; Smoking Cessation; Stress Disorders, Post-Traumatic; Tachycardia, Supraventricular; Telangiectasia, Hereditary Hemorrhagic; Ventricular Fibrillation; Cardiovascular Diseases
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Sodium channel alpha subunit blocker
ROUTE OF ADMINISTRATION: INTRAVENOUS; ORAL
STATUS: Approved
THERAPEUTIC AREA: NEUROLOGY DRUGS & NERVOUS SYSTEM; OTHER; PEDIATRICS
THERAPEUTIC INDICATION: Hepatitis B, Chronic; Cocaine-Related Disorders; Epilepsy, Reflex; HIV Infections; Nausea; Anxiety; Dementia; Depressive Disorder; Schizophrenia; Bipolar Disorder; Epilepsies, Partial; Epilepsy; Glossopharyngeal Nerve Diseases; Seizures; Trigeminal Neuralgia
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Carcinoma, Hepatocellular; Meningeal Carcinomatosis; Thalassemia; Acute Kidney Injury; Anemia, Sickle Cell; Breast Neoplasms; Cerebral Hemorrhage; Diabetic Foot; Ischemic Stroke; Subarachnoid Hemorrhage; Hemochromatosis; Severe Acute Respiratory Syndrome; beta-Thalassemia
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Anandamide amidohydrolase inhibitor
ROUTE OF ADMINISTRATION: INJECTION; INTRAVENOUS; ORAL; RECTAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Arrhythmias, Cardiac; Crohn Disease; Diabetes Mellitus, Type 2; Glycogen Storage Disease Type II; Hepatitis B, Chronic; Immune System Diseases; Intervertebral Disc Degeneration; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Nervous System Diseases; Obesity, Morbid; Parkinson Disease; Pruritus; Purpura, Thrombocytopenic, Idiopathic; Anxiety; Arthritis, Rheumatoid; Borderline Personality Disorder; Brain Injuries; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Cleft Palate; Diabetes Mellitus, Type 1; Digestive System Diseases; Fractures, Bone; Glioma; Graft vs Host Disease; Head and Neck Neoplasms; Hypertension; Hypertrophy; Immunoglobulin G4-Related Disease; Leukemia, Mast-Cell; Leukemia, Myeloid, Acute; Leukemia, T-Cell; Lymphoma; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Melanoma; Mucositis; Multiple Myeloma; Myelodysplastic Syndromes; Neck Pain; Neuralgia; Pre-Eclampsia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Pulpitis; Renal Colic; Rotator Cuff Injuries; Sinusitis; Tension-Type Headache; Tonsillitis; Abdominal Pain; Chronic Pain; Delirium; Diabetic Neuropathies; Ductus Arteriosus, Patent; HIV Infections; Hemorrhage; Hypospadias; Infections; Kidney Calculi; Kidney Diseases; Low Back Pain; Lupus Erythematosus, Systemic; Lupus Nephritis; Malaria; Malaria, Falciparum; Meningitis, Bacterial; Multiple Sclerosis; Myopia; Nausea; Neoplasms; Obesity; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Paget Disease, Extramammary; Pemphigus; Postoperative Nausea and Vomiting; Respiratory Tract Infections; Scoliosis; Sepsis; Severe Acute Respiratory Syndrome; Streptococcal Infections; Vomiting; Wounds and Injuries; Acute Pain; Arthritis; Back Pain; Common Cold; Dysmenorrhea; Fever; Headache; Influenza, Human; Migraine Disorders; Muscle Cramp; Pain; Pharyngitis; Toothache
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Progesterone receptor agonist
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Endometrial Neoplasms; Hemorrhage
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Mood Disorders; Attention Deficit Disorder with Hyperactivity; Cerebral Infarction; Cocaine-Related Disorders; Diabetes Mellitus, Type 2; Hepatitis C; Infections; Influenza, Human; Pain; Stroke; Hepatitis C, Chronic; Multiple Sclerosis; Psychotic Disorders; Schizophrenia; Severe Acute Respiratory Syndrome; Parkinson Disease
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Bacteremia; Gram-Positive Bacterial Infections; Bacterial Infections
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Cell membrane inhibitor
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Unknown
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Amidophosphoribosyltransferase inhibitor
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Inflammatory Bowel Diseases; Mucopolysaccharidoses; Myelodysplastic Syndromes; Urticaria; Anemia, Sickle Cell; Gout; Hepatitis, Autoimmune; Idiopathic Pulmonary Fibrosis; Infertility; Leukemia, Myeloid, Acute; Lung Diseases; Lung Diseases, Interstitial; Pemphigoid, Bullous; Pemphigus; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Carcinoma, Hepatocellular; Cardiomyopathies; Churg-Strauss Syndrome; Colitis, Ulcerative; Crohn Disease; Eczema; Encephalomyelitis; Glomerulonephritis, IGA; Granulomatosis with Polyangiitis; Lupus Erythematosus, Systemic; Lupus Nephritis; Microscopic Polyangiitis; Myasthenia Gravis; Neuromyelitis Optica; Pulmonary Fibrosis; Renal Insufficiency, Chronic; Takayasu Arteritis; Thrombocytopenia; Vasculitis; Arthritis, Rheumatoid; Immune System Diseases
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Mu opioid receptor agonist
ROUTE OF ADMINISTRATION: BUCCAL; SUBLINGUAL; TRANSDERMAL
STATUS: Approved
THERAPEUTIC AREA: CANCER; NEUROLOGY DRUGS & NERVOUS SYSTEM; OTHER
THERAPEUTIC INDICATION: Opioid-Related Disorders; Respiratory Distress Syndrome; Brain Injuries; Breast Neoplasms; Bronchial Spasm; Delirium; Fractures, Bone; Hypospadias; Hypotension; Irritable Bowel Syndrome; Pulpitis; Scoliosis; Subarachnoid Hemorrhage; Abscess; Adenoma; Aortic Coarctation; Diabetic Neuropathies; Liver Diseases; Low Back Pain; Neoplasm Metastasis; Obesity; Obesity, Morbid; Osteoarthritis; Pancreatic Neoplasms; Renal Insufficiency, Chronic; Respiratory Insufficiency; Severe Acute Respiratory Syndrome; Sleep Apnea, Obstructive; Stomach Neoplasms; Acute Pain; Cancer Pain; Chronic Pain; Migraine Disorders; Neoplasms; Pain
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Unknown
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Glucocorticoid receptor agonist
ROUTE OF ADMINISTRATION: OPHTHALMIC
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Eye Diseases
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: DNA inhibitor
ROUTE OF ADMINISTRATION: INJECTION
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Alopecia; Brain Neoplasms; Glioblastoma; Leukemia, Plasma Cell; Polycythemia Vera; Primary Myelofibrosis; Thrombocythemia, Essential; Blast Crisis; Burkitt Lymphoma; Central Nervous System Neoplasms; Hematologic Neoplasms; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myelomonocytic, Juvenile; Leukemia-Lymphoma, Adult T-Cell; Lupus Erythematosus, Systemic; Lymphoma, AIDS-Related; Lymphoma, Large-Cell, Anaplastic; Lymphoma, T-Cell, Peripheral; Medulloblastoma; Meningitis, Aseptic; Multiple Sclerosis, Relapsing-Remitting; Myasthenia Gravis; Neuromyelitis Optica; Neutropenia; Opsoclonus-Myoclonus Syndrome; Ovarian Neoplasms; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Prostatic Neoplasms, Castration-Resistant; Sarcoma; Stiff-Person Syndrome; Anemia, Refractory; Anemia, Refractory, with Excess of Blasts; Breast Neoplasms; Graft vs Host Disease; Histiocytosis, Langerhans-Cell; Hodgkin Disease; Leukemia; Leukemia, Basophilic, Acute; Leukemia, Biphenotypic, Acute; Leukemia, Erythroblastic, Acute; Leukemia, Megakaryoblastic, Acute; Leukemia, Monocytic, Acute; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myelomonocytic, Acute; Leukemia, Myelomonocytic, Chronic; Leukemia, Promyelocytic, Acute; Lymphoma; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Malaria; Melanoma; Multiple Myeloma; Myelodysplastic Syndromes; Myeloproliferative Disorders; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Renal Insufficiency, Chronic; Sarcoma, Myeloid; Urinary Bladder, Overactive; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Meningeal Carcinomatosis; Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Breast Neoplasms; Irritable Bowel Syndrome; Sleep Wake Disorders; Anxiety; Dementia; Schizophrenia; Urticaria; Depressive Disorder; Pruritus
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Leishmaniasis; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Glioblastoma; Central Nervous System Neoplasms; Hodgkin Disease; Lymphoma; Neoplasms
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Cytochrome P450 19A1 inhibitor
ROUTE OF ADMINISTRATION: INJECTION; ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Puberty, Precocious
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: 70S ribosome inhibitor
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Bacterial Infections
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Unknown
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Unknown
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Unknown
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Glucocorticoid receptor agonist
ROUTE OF ADMINISTRATION: INJECTION
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Arthritis, Rheumatoid; Joint Diseases; Pain; Eye Diseases; Hemorrhoids; Lung Diseases, Obstructive; Nasal Obstruction; Osteoarthritis
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Sepsis; Periapical Periodontitis; Prediabetic State; Severe Acute Respiratory Syndrome; Breast Neoplasms; Candidiasis, Vulvovaginal; Chorioretinitis; Kidney Calculi; Malaria; Nasal Obstruction; Pain; Pneumonia, Pneumocystis; Skin Diseases; Staphylococcal Infections; Vaginosis, Bacterial; Acne Vulgaris; Bacterial Infections; Endometritis; Infections; Intraabdominal Infections; Osteomyelitis
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Copper chelating agent
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Central Nervous System Neoplasms; Arthritis, Rheumatoid; Cystinuria; Hepatolenticular Degeneration; Inflammation; Rheumatic Diseases; Spondylitis
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Dermatitis, Atopic; Epidermolysis Bullosa Dystrophica; Muscular Dystrophy, Duchenne; Pneumonia, Ventilator-Associated; Chorioamnionitis; Cystic Fibrosis; Diabetic Foot; Folliculitis; Leishmaniasis; Leishmaniasis, Cutaneous; Meniere Disease; Neoplasms; Plague; Breast Neoplasms; Cat-Scratch Disease; Colonic Neoplasms; Eczema; Infections; Pain; Rectal Neoplasms; Sepsis; Bacterial Infections; Eye Infections
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Dopamine D3 receptor agonist
ROUTE OF ADMINISTRATION: INHALATION; ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Amyotrophic Lateral Sclerosis; Asthma; Hypotension, Orthostatic; Tobacco Use Disorder; Tourette Syndrome; Albinism; Albinism, Oculocutaneous; Angelman Syndrome; Aphasia; Back Pain; Child Development Disorders, Pervasive; Chronic Pain; Cocaine-Related Disorders; Macular Degeneration; Pain; Retinitis Pigmentosa; Schizophrenia; Spinal Cord Injuries; Stress Disorders, Post-Traumatic; Amblyopia; Restless Legs Syndrome; Stroke; Parkinson Disease
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Polyuria; Urinary Incontinence
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Cytochrome P450 11A1 inhibitor
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Prostatic Neoplasms, Castration-Resistant; Adrenal Cortex Neoplasms; Carcinoma; Neoplasms
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: DNA inhibitor
ROUTE OF ADMINISTRATION: INJECTION
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Sarcoma, Ewing; Neoplasms
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Cognitive Dysfunction; Fatigue; Head and Neck Neoplasms; Heart Arrest; Marijuana Abuse; Mental Disorders; Opioid-Related Disorders; Perceptual Disorders; Respiratory Insufficiency; Schizophrenia; Sepsis; Stroke; Substance-Related Disorders; Tobacco Use Disorder; Borderline Personality Disorder; Brain Injuries; Breast Neoplasms; Bronchial Spasm; Cataract; Child Development Disorders, Pervasive; Cocaine-Related Disorders; Complex Regional Pain Syndromes; Coronavirus Infections; Depressive Disorder, Treatment-Resistant; Epilepsy; Fractures, Multiple; Heart Septal Defects, Ventricular; Hypertrophy; Ischemic Stroke; Lung Neoplasms; Obsessive-Compulsive Disorder; Paget Disease, Extramammary; Respiratory Distress Syndrome; Rett Syndrome; Severe Acute Respiratory Syndrome; Strabismus; Stress Disorders, Post-Traumatic; Subarachnoid Hemorrhage; Temporomandibular Joint Disorders; Alcoholism; Anemia, Sickle Cell; Bipolar Disorder; Chronic Pain; Delirium; Depression, Postpartum; Depressive Disorder; Depressive Disorder, Major; Fractures, Bone; Headache; Mucositis; Neoplasms; Neuralgia; Obesity, Morbid; Pain; Pharyngitis; Postoperative Complications; Renal Colic; Rib Fractures; Shock, Septic; Status Asthmaticus; Status Epilepticus; Suicidal Ideation; Wounds and Injuries
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Sleep Initiation and Maintenance Disorders; Anxiety; Dementia; Depressive Disorder; Schizophrenia
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Bacterial penicillin-binding protein inhibitor
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Unknown
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Thymidylate synthase inhibitor
ROUTE OF ADMINISTRATION: INJECTION
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Colonic Neoplasms; Fallopian Tube Neoplasms; Rectal Neoplasms; Carcinoid Tumor; Carcinoma, Hepatocellular; Cholangiocarcinoma; Esophageal Neoplasms; Gastrointestinal Stromal Tumors; Liver Neoplasms; Ovarian Neoplasms; Peritoneal Neoplasms; Stomach Neoplasms; Colorectal Neoplasms; Neoplasms
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Bacterial dihydropteroate synthase inhibitor
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Bacterial Infections; Eye Infections
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Retinoic acid receptor agonist
ROUTE OF ADMINISTRATION: ORAL; TOPICAL
STATUS: Approved
THERAPEUTIC AREA: DERMATOLOGY; OTHER
THERAPEUTIC INDICATION: Amyotrophic Lateral Sclerosis; Hematologic Neoplasms; Myelodysplastic-Myeloproliferative Diseases; Anemia; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Carcinoma, Adenoid Cystic; Cholangitis, Sclerosing; Emphysema; Keratosis, Actinic; Kidney Neoplasms; Lentigo; Lung Neoplasms; Lymphoma; Melanoma; Multiple Myeloma; Neuroblastoma; Pancreatic Neoplasms; Prostatic Neoplasms; Severe Acute Respiratory Syndrome; Small Cell Lung Carcinoma; Striae Distensae; Breast Neoplasms; Carcinoma, Basal Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Leukemia; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Myeloproliferative Disorders; Purpura, Thrombocytopenic, Idiopathic; Rosacea; Acne Vulgaris; Hyperpigmentation; Leukemia, Promyelocytic, Acute; Melanosis; Neoplasms
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Alcoholism; Autistic Disorder; Brain Injuries; Carcinoma, Non-Small-Cell Lung; Cerebral Hemorrhage; Child Development Disorders, Pervasive; Cholangitis, Sclerosing; Fibromyalgia; Glioblastoma; Glioma; Hemorrhage; Macular Edema; Memory Disorders; Periapical Periodontitis; Pneumonia; Retinal Vein Occlusion; Skin Diseases; Angelman Syndrome; Asthma; Atrial Fibrillation; Carotid Stenosis; Chronic Pain; Colorectal Neoplasms; Cystic Fibrosis; Depressive Disorder, Major; Esophageal Neoplasms; Fragile X Syndrome; HIV Infections; Head and Neck Neoplasms; Huntington Disease; Impetigo; Lung Neoplasms; Macular Degeneration; Multiple Myeloma; Multiple Sclerosis, Relapsing-Remitting; Neuralgia; Obsessive-Compulsive Disorder; Oropharyngeal Neoplasms; Pancreatic Neoplasms; Parkinson Disease; Retinal Detachment; Retinitis Pigmentosa; Stroke; Amyotrophic Lateral Sclerosis; Arthritis, Rheumatoid; Bipolar Disorder; Depressive Disorder; Depressive Disorder, Treatment-Resistant; Heroin Dependence; Hypertension; Idiopathic Pulmonary Fibrosis; Lichen Planus, Oral; Multiple Sclerosis; Neurobehavioral Manifestations; Peri-Implantitis; Periodontitis; Pneumothorax; Psychotic Disorders; Rosacea; Schizophrenia; Spinal Cord Injuries; Acne Vulgaris; Bacterial Infections; Infections